Nama's AI scorecard currently rates Omega Healthcare Investors Buy (6.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.

What is OHI's P/E ratio?

Omega Healthcare Investors trades at a trailing price-to-earnings ratio of 17.6.

When does OHI report earnings?

Omega Healthcare Investors's next scheduled report is on Feb 3, 2027. Analysts expect EPS of $0.34.

What is the OHI price target?

The median analyst price target from 19 analysts is $52.00, with a range of $45.00 – $61.00.

Is OHI Shariah compliant?

Nama's AAOIFI-style screen reads Omega Healthcare Investors as Not Shariah Compliant. At least one of the three ratios or the industry test failed.

Does OHI pay a dividend?

Yes — Omega Healthcare Investors's dividend yield is 5.6%.

Nama Insights

Omega Healthcare Investors (OHI)

Real Estate · Reit Healthcare Facilities · NYSE

Omega Healthcare Investors (OHI) is a Real Estate company in the Reit Healthcare Facilities industry. It has a market capitalization of $15.34B and a trailing price-to-earnings ratio of 17.6. Over the most recent reported fiscal year, revenue grew 13.2%. Nama's AI scorecard rates it Buy, 6.5 out of 10. On 12-month momentum it ranks in the middle band of its market.

AI scorecard

Buy · 6.5/10

Positive, at the low end of Buy. As of Nov 7, 2026.

Momentum

Middle · +2.6% over 12 months ex. last

Middle fifth of its market on the past year's move.

Shariah screen

Not Shariah Compliant

At least one of the three ratios or the industry test failed.

Off its high

-8.0%

How far the last close sits under the highest price of the past five years.

Market cap	$15.34B
Trailing P/E	17.6
Price / book	2.7
Price / sales	12.2
FCF yield	—
Dividend yield	5.6%
Gross margin	97.4%
Operating margin	63.0%
Net margin	67.0%
Revenue growth (YoY)	+13.2%
Revenue growth (3-yr annual)	+10.7%
EPS growth (YoY)	+23.8%
FCF/share growth (YoY)	—
Beta	0.5
Exchange	NYSE
Sector	Real Estate
Industry	Reit Healthcare Facilities

OHI earnings

Next report: Feb 3, 2027 (Q4 2026, EPS estimate $0.34). Beat the EPS estimate in 3 of 4 recent quarters.

Quarter	Reported	EPS	Estimate	Surprise	Revenue
Q3 2026	Nov 3, 2026	$0.50	$0.48	+4.2%	$340.55M
Q2 2026	Jul 29, 2026	$1.22	$0.48	+154.2%	$328.25M
Q1 2026	Apr 28, 2026	$0.48	$0.49	-2.0%	$322.95M
Q4 2025	Feb 4, 2026	$0.53	$0.50	+6.0%	$319.22M

OHI analyst price target

Median target $52.00 from 19 analysts, ranging $45.00 – $61.00.

Reit Healthcare Facilities peers

Ticker	Company	Market cap	P/E
WELL	Welltower	$179.74B	106.1
VTR	Ventas	$46.93B	164.3
DOC	Healthpeak Properties	$14.71B	40.5
AHR	American Healthcare REIT	$12.62B	103.4
CTRE	CareTrust REIT	$9.03B	25.1
HR	Healthcare Realty Trust	$6.66B	—
SBRA	Sabra Health Care REIT	$5.51B	31.9
NHI	National Health Investors	$3.50B	21.1

Explore live OHI data on Nama Insights →

Recent Congressional trades

Omega Healthcare Investors trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Thomas R Carper	Senate	Sell	$1,001 - $15,000	—
Thomas R Carper	Senate	Sell	$1,001 - $15,000	—
Susan M Collins	Senate	Sell	$1,001 - $15,000	—

OHI FAQ

Is OHI a buy?: Nama's AI scorecard currently rates Omega Healthcare Investors Buy (6.5 out of 10), a call computed from its profitability, cash generation, growth, valuation and balance sheet. It is a research reading, not investment advice.
What is OHI's P/E ratio?: Omega Healthcare Investors trades at a trailing price-to-earnings ratio of 17.6.
When does OHI report earnings?: Omega Healthcare Investors's next scheduled report is on Feb 3, 2027. Analysts expect EPS of $0.34.
What is the OHI price target?: The median analyst price target from 19 analysts is $52.00, with a range of $45.00 – $61.00.
Is OHI Shariah compliant?: Nama's AAOIFI-style screen reads Omega Healthcare Investors as Not Shariah Compliant. At least one of the three ratios or the industry test failed.
Does OHI pay a dividend?: Yes — Omega Healthcare Investors's dividend yield is 5.6%.